
News
UK Pharmaceutical Company’s $130m Punt On French Cannabis Patent
PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders. The London-listed company has agreed an upfront $30m rights deal

PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders. The London-listed company has agreed an upfront $30m rights deal